LakeShore Biopharma Co., Ltd. (LSBCF) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2025-11-04
08:50 am
Unchanged		2025-11-0413DLakeShore Biopharma Co., Ltd
LSBCF		Crystal Peak Investment Inc.21,021,332
51.000%		0
(Unchanged)		Filing
History
2025-10-29
08:05 am
Unchanged		2025-10-2713DLakeShore Biopharma Co., Ltd
LSBCF		Crystal Peak Investment Inc.21,021,332
51.000%		0
(Unchanged)		Filing
History
2025-08-27
09:02 am
Unchanged		2025-08-2613DLakeShore Biopharma Co., Ltd
LSBCF		Crystal Peak Investment Inc.21,021,332
51.000%		0
(Unchanged)		Filing
History
2025-07-22
08:57 am
Purchase		2025-07-0813DLakeShore Biopharma Co., Ltd
LSBCF		Crystal Peak Investment Inc.21,021,332
51.000%		21,021,332increase
(New Position)		Filing
History
2025-07-15
4:01 pm
Purchase		2025-07-1113DLakeShore Biopharma Co., Ltd
LSBCF		Fung Ching Wong9,836,010
23.900%		9,836,010increase
(New Position)		Filing
History
2024-02-16
4:14 pm
Unchanged		2024-02-1613GLakeShore Biopharma Co., Ltd
LSB		Zhang3,960,119
42.600%		0
(Unchanged)		Filing
History
2024-02-15
4:24 pm
Purchase		2023-12-3113GLakeShore Biopharma Co., Ltd
LSB		Zhang3,960,119
42.600%		3,960,119increase
(New Position)		Filing
History
2024-02-14
11:23 am
Purchase		2024-02-0713DLakeShore Biopharma Co., Ltd
LSB		Fung Ching Wong9,836,009
52.230%		9,836,009increase
(New Position)		Filing
History